These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

368 related articles for article (PubMed ID: 29843214)

  • 41. Bioinformatic analysis reveals CYP2C9 as a potential prognostic marker for HCC and liver cancer cell lines suitable for its mechanism study.
    Shuaichen L; Guangyi W
    Cell Mol Biol (Noisy-le-grand); 2018 May; 64(7):70-74. PubMed ID: 29974848
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Prognostic value of aberrantly expressed methylation genes in human hepatocellular carcinoma.
    Zhen L; Ning G; Wu L; Zheng Y; Yang F; Chen T; Xu W; Liu Y; Xie C; Peng L
    Biosci Rep; 2020 Oct; 40(10):. PubMed ID: 32955083
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Bioinformatics analysis to identify the key genes affecting the progression and prognosis of hepatocellular carcinoma.
    Zhang Y; Wang S; Xiao J; Zhou H
    Biosci Rep; 2019 Feb; 39(2):. PubMed ID: 30705088
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Diagnostic significance and potential function of miR-338-5p in hepatocellular carcinoma: A bioinformatics study with microarray and RNA sequencing data.
    Liang L; Gao L; Zou XP; Huang ML; Chen G; Li JJ; Cai XY
    Mol Med Rep; 2018 Feb; 17(2):2297-2312. PubMed ID: 29207053
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Identification of Differentially Expressed Genes (DEGs) Relevant to Prognosis of Ovarian Cancer by Use of Integrated Bioinformatics Analysis and Validation by Immunohistochemistry Assay.
    Zhang L; Sun L; Zhang B; Chen L
    Med Sci Monit; 2019 Dec; 25():9902-9912. PubMed ID: 31871312
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Bioinformatics-based screening of key genes for transformation of liver cirrhosis to hepatocellular carcinoma.
    Jiang CH; Yuan X; Li JF; Xie YF; Zhang AZ; Wang XL; Yang L; Liu CX; Liang WH; Pang LJ; Zou H; Cui XB; Shen XH; Qi Y; Jiang JF; Gu WY; Li F; Hu JM
    J Transl Med; 2020 Jan; 18(1):40. PubMed ID: 32000807
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Cancer-Testis Gene Expression in Hepatocellular Carcinoma: Identification of Prognostic Markers and Potential Targets for Immunotherapy.
    Zhang YP; Bao ZW; Wu JB; Chen YH; Chen JR; Xie HY; Zhou L; Wu J; Zheng SS
    Technol Cancer Res Treat; 2020; 19():1533033820944274. PubMed ID: 32715976
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Identification of prostate cancer hub genes and therapeutic agents using bioinformatics approach.
    Fang E; Zhang X; Wang Q; Wang D
    Cancer Biomark; 2017 Dec; 20(4):553-561. PubMed ID: 28800317
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Investigation of hypoxia networks in ovarian cancer via bioinformatics analysis.
    Zhang K; Kong X; Feng G; Xiang W; Chen L; Yang F; Cao C; Ding Y; Chen H; Chu M; Wang P; Zhang B
    J Ovarian Res; 2018 Feb; 11(1):16. PubMed ID: 29482638
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Identification of Hub Genes in Anaplastic Thyroid Carcinoma: Evidence From Bioinformatics Analysis.
    Li L; Zhu M; Huang H; Wu J; Meng D
    Technol Cancer Res Treat; 2020; 19():1533033820962135. PubMed ID: 33025856
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Identification of Drug Targets and Agents Associated with Hepatocellular Carcinoma through Integrated Bioinformatics Analysis.
    Hossen MA; Reza MS; Harun-Or-Roshid M; Islam MA; Siddika MA; Mollah MNH
    Curr Cancer Drug Targets; 2023; 23(7):547-563. PubMed ID: 36786134
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Target gene screening and evaluation of prognostic values in non-small cell lung cancers by bioinformatics analysis.
    Piao J; Sun J; Yang Y; Jin T; Chen L; Lin Z
    Gene; 2018 Mar; 647():306-311. PubMed ID: 29305979
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Identification of Key Biological Processes, Pathways, Networks, and Genes with Potential Prognostic Values in Hepatocellular Carcinoma Using a Bioinformatics Approach.
    Lu H; Zhu Q
    Cancer Biother Radiopharm; 2021 Dec; 36(10):837-849. PubMed ID: 32598174
    [No Abstract]   [Full Text] [Related]  

  • 54. Molecular Mechanism of Aflatoxin-Induced Hepatocellular Carcinoma Derived from a Bioinformatics Analysis.
    Cai P; Zheng H; She J; Feng N; Zou H; Gu J; Yuan Y; Liu X; Liu Z; Bian J
    Toxins (Basel); 2020 Mar; 12(3):. PubMed ID: 32210020
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The identification of key biomarkers in patients with lung adenocarcinoma based on bioinformatics.
    Ni KW; Sun GZ
    Math Biosci Eng; 2019 Aug; 16(6):7671-7687. PubMed ID: 31698633
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Bioinformatics analysis of gene expression alterations in microRNA‑122 knockout mice with hepatocellular carcinoma.
    He B; He Y; Shi W; Gong S; Chen X; Xiao J; Gu J; Ding W; Wang Y
    Mol Med Rep; 2017 Jun; 15(6):3681-3689. PubMed ID: 28393247
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Identification of Biological Targets of Therapeutic Intervention for Hepatocellular Carcinoma by Integrated Bioinformatical Analysis.
    Hu WQ; Wang W; Fang DL; Yin XF
    Med Sci Monit; 2018 May; 24():3450-3461. PubMed ID: 29795057
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Identification and Characterization of Cadmium-Related Genes in Liver Carcinoma.
    Zhang L; Huang Y; Zhu Y; Yu Z; Shao M; Luo Y
    Biol Trace Elem Res; 2018 Apr; 182(2):238-247. PubMed ID: 28791617
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Bioinformatics Analysis Reveals Distinct Molecular Characteristics of Hepatitis B-Related Hepatocellular Carcinomas from Very Early to Advanced Barcelona Clinic Liver Cancer Stages.
    Kong FY; Wei X; Zhou K; Hu W; Kou YB; You HJ; Liu XM; Zheng KY; Tang RX
    PLoS One; 2016; 11(7):e0158286. PubMed ID: 27454179
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Bioinformatics analysis of key genes and prognosis-related genes during the onset of hepatocellular carcinoma].
    Zhou ZW; Zhou XG; Liu YC; Qiu MQ; Wen QP; Zhou ZH; Jiang YJ; Feng SX; Yu HP
    Zhonghua Gan Zang Bing Za Zhi; 2020 Aug; 28(8):686-691. PubMed ID: 32911908
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.